Patent ReferencesSurface modified drug nanoparticles Hydrophobic drug delivery systems Patent #: 5430021 InventorsApplicationNo. 384057 filed on 02/06/1995US Classes:424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/450, Liposomes424/495, Ethyl cellulose424/498, Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof424/499, Contains proteins or derivative or polysaccharides or derivative514/772.1, Aftertreated solid synthetic organic polymer (e.g., grafting, blocking, etc.)514/937, DISPERSION OR EMULSION514/938, Oil-water type514/951POWDERS, GRANULES OR PARTICLES OF SPECIFIED MESH OR PARTICLE SIZEExaminersPrimary: Page, Thurman K.Assistant: Howard, Sharon Attorney, Agent or FirmInternational ClassA61K 009/14AbstractNanoparticulate crystalline drug substances formulated in an aqueos phase emulsified in oil, are able to be made at less than 1000 nm size and provide increased bioavailability and lymphatic uptake following oral administration.Field of SearchParticulate form (e.g., powders, granules, beads, microcapsules, and pellets)Liposomes Ethyl cellulose Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof Contains proteins or derivative or polysaccharides or derivative POWDERS, GRANULES OR PARTICLES OF SPECIFIED MESH OR PARTICLE SIZE Aftertreated solid synthetic organic polymer (e.g., grafting, blocking, etc.) | |